Detalles de la búsqueda
1.
Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry.
Pharmacoepidemiol Drug Saf
; 33(4): e5789, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38629216
2.
Sex differences in peer and parental risk factors for non-medical use of prescription opioids in youth.
Am J Drug Alcohol Abuse
; 46(2): 203-215, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31603348
3.
Age of First Use of Prescription Opioids and Prescription Opioid Non-Medical Use among Older Adolescents.
Subst Use Misuse
; 55(14): 2420-2427, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33059498
4.
Power of the Peer and Parent: Gender Differences, Norms, and Nonmedical Prescription Opioid Use Among Adolescents in South Central Kentucky.
Prev Sci
; 20(5): 665-673, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30637670
5.
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
BMJ Evid Based Med
; 27(1): 1-6, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33087452
6.
Prescription Opioid Use Among a Community Sample of Older and Younger Women.
J Womens Health (Larchmt)
; 31(2): 270-278, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826866
7.
Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion.
Pharmacoepidemiol Drug Saf
; 25(4): 476, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27059544
8.
Opioids in the United Kingdom: safety and surveillance during COVID-19.
Curr Opin Psychiatry
; 34(4): 357-362, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33993168
9.
The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology.
Drug Saf
; 44(8): 835-841, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33961212
10.
A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events.
Front Pharmacol
; 12: 726141, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34421619
11.
Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study.
BMJ Open
; 10(11): e038102, 2020 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33148732
12.
Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study.
PLoS One
; 15(10): e0240489, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33035259
13.
Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England.
Ther Adv Psychopharmacol
; 10: 2045125320954616, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32953041
14.
If kids ruled the world, how would they stop non-medical use of prescription drugs?
J Health Res
; 34(4): 283-294, 2020 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34296069
15.
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
Drug Saf
; 43(7): 645-656, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32468196
16.
Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management.
BMJ Evid Based Med
; 25(6): 199-205, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094200
17.
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment.
Drug Saf
; 43(8): 809-821, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32578156
18.
Sex differences in patterns of prescription opioid non-medical use among 10-18â¯year olds in the US.
Addict Behav
; 89: 163-171, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30316142
19.
A Longitudinal Analysis of the Substance Abuse, Violence, and HIV/AIDS (SAVA) Syndemic among Women in the Criminal Justice System.
J Psychoactive Drugs
; 51(1): 58-67, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30626264
20.
Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System.
Drug Saf
; 41(3): 313-320, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29098610